-+ 0.00%
-+ 0.00%
-+ 0.00%

PEPGEN - TO USE NET PROCEEDS FOR CLINICAL DEVELOPMENT AND CORPORATE PURPOSES

Reuters·11/10/2026 21:23:00

Please log in to view news